Athersys Overview

  • Founded
  • 1995
Founded
  • Status
  • Public
  • Employees
  • 83
Employees
  • Stock Symbol
  • ATHX
Stock Symbol
  • Share Price
  • $1.61
  • (As of Friday Closing)

Athersys General Information

Description

Athersys Inc is a clinical-stage biotechnology company. It is focused on developing novel and proprietary therapies in the areas where there is a significant unmet medical need, particularly in the regenerative medicine area. The firm's main product is Multistem cell therapy. Its current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders and certain pulmonary conditions. Its revenue has been derived from corporate collaborations, license agreements, and government grants.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 3201 Carnegie Avenue
  • Cleveland, OH 44115
  • United States
+1 (216) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Athersys Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.61 $1.66 $1.13 - $4.38 $318M 197M 1.94M -$0.33

Athersys Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 510,435 152,254 156,147 186,312
Revenue 10 5,633 24,291 3,708
EBITDA (55,542) (43,884) (23,428) (31,557)
Net Income (55,954) (44,582) (24,283) (32,241)
Total Assets 86,436 41,666 61,730 33,593
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Athersys Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Athersys‘s full profile, request access.

Request a free trial

Athersys Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Athersys Inc is a clinical-stage biotechnology company. It is focused on developing novel and proprietary therapies in t
Pharmaceuticals
Cleveland, OH
83 As of 2019
0000
000000000 0000

00000000

didunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco
0000000000000
Beverly Hills, CA
00 As of 0000
000.00
000000000 - 000.00

00000000

ua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo
0000000000000
Basel, Switzerland
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Athersys Competitors (34)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Capricor Therapeutics Formerly VC-backed Beverly Hills, CA 00 000.00 000000000 - 000.00
0000000000 Corporate Backed or Acquired Basel, Switzerland 000000&0
000 0000000 Corporation King Of Prussia, PA 00000
0000000 0000000000 Venture Capital-Backed San Diego, CA 00 00000 00000000000 00000
00000000 000000000 Corporate Backed or Acquired San Diego, CA 000 00000 000000&0
You’re viewing 5 of 34 competitors. Get the full list »

Athersys Executive Team (10)

Name Title Board Seat Contact Info
Gil Van Bokkelen Ph.D Chief Executive Officer & Chairman
William Lehmann Jr. Chief Operating Officer, Operations & President
Ivor Macleod Chief Financial Officer, Finance
Laura Campbell Chief Accounting Officer, Accounting & Senior Vice President
John Harrington Ph.D Co-Founder, Board Member, Executive Vice President and Chief Scientific Officer
You’re viewing 5 of 10 executive team members. Get the full list »

Athersys Board Members (15)

Name Representing Role Since
000 000 00000000 00.0 Athersys Chief Executive Officer & Chairman 000 0000
00000 00000000 Athersys Board Member 000 0000
000000 0000 00.0 Self Board Member 000 0000
0000 000000000000 Self Board Member 000 0000
0000 0000000 Self Board Member 000 0000
You’re viewing 5 of 15 board members. Get the full list »

Athersys Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Athersys Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Athersys‘s full profile, request access.

Request a free trial